Viewing nowSamsung Rosuvastatin Tablets 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samsung Pharm Co., Ltd.

MFDS item code 201900332 · Approved 2019.01.22 · Insurance code 642307300
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used for various types of dyslipidemia associated with hypercholesterolemia. In particular, it is used as an adjunctive therapy when diet and exercise do not improve primary hypercholesterolemia and mixed dyslipidemia patients. It also helps patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia in conjunction with a dietary regimen. It can also be used as an adjunctive therapy for pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet specific criteria. This medication lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and helping to reduce the risk of cardiovascular diseases. It can be expected to reduce the risk of cardiovascular complications such as stroke, myocardial infarction, and arterial revascularization.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals with allergies to its components, severely impaired liver function, muscle diseases, those taking specific immunosuppressants, severely impaired renal function, pregnant or breastfeeding women, and those with lactose intolerance should not take this medication. Moreover, it is important to periodically check liver function tests and muscle conditions before and during treatment with this drug. Patients with a history of liver disease or those who consume alcohol excessively should be especially cautious, and if high cholesterol is caused by conditions like hypothyroidism or nephrotic syndrome, these issues must be treated first. If symptoms such as muscle pain, muscle weakness, or myopathy occur, contact a physician immediately for testing. If severe muscle damage occurs, the usage of this medication should be stopped, and it may be restarted at a lower dose once symptoms improve. This medication can interact with other drugs, so there should be caution when taken in conjunction with certain antiviral medications, immunosuppressants, fibrates, and some antibiotics. Consultation with a physician is needed as the risk of muscle damage may increase when used in combination. Women who are pregnant or may become pregnant should not take this medication and should use appropriate contraception. Nursing mothers should also avoid taking this medication. In cases of overdose, there is no specific antidote, and symptomatic treatment as well as liver function and muscle enzyme testing are required. Be careful as dizziness may occur while driving or operating machinery. Finally, this medication may increase blood sugar levels in some patients, so individuals at high risk for diabetes should have their blood sugar levels checked regularly while taking this medication.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the drug's efficacy and safety for a long period.
Pink round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samsung Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.